Metabolic Syndrome and Cardiovascular Risk

Metabolic syndrome, characterized by a cluster of conditions including obesity, insulin resistance, hypertension, and dyslipidemia, significantly increases cardiovascular risk. This syndrome accelerates the development of atherosclerosis, leading to higher chances of heart disease, stroke, and peripheral artery disease. Central obesity, often associated with metabolic syndrome, contributes to chronic inflammation and endothelial dysfunction, further elevating cardiovascular risk. Managing metabolic syndrome involves lifestyle modifications such as weight loss, physical activity, and dietary changes to improve insulin sensitivity and reduce blood pressure and lipid levels. Pharmacological interventions may also be necessary to address specific components of the syndrome. Early identification and comprehensive management are crucial for reducing cardiovascular risk and improving overall health outcomes.

 

    Related Conference of Metabolic Syndrome and Cardiovascular Risk

    September 23-24, 2024

    5th Global Summit on Environmental Health

    Amsterdam, Netherlands
    October 14-15, 2024

    3rd World Congress on Climate change and Ecosystem

    Madrid, Spain
    November 28-29, 2024

    19th World Convention on Waste Recycling and Reuse

    Aix-en-Provence, France
    February 13-14, 2025

    4th World Congress on Endocrinology & Diabetes

    Rome, Italy
    February 24-25, 2025

    4th World Congress on Sustainable Waste Management

    Madrid, Spain
    April 14-15, 2025

    13th World Conference on Climate Change

    Aix-en-Provence, France
    June 16-17, 2025

    20th World Bioenergy Congress and Expo

    Frankfurt, Germany
    August 26-27, 2025

    13th International Conference on Green Energy

    Paris, France

    Metabolic Syndrome and Cardiovascular Risk Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in